Pharmacogenomics is at the forefront of personalized medicine development. Recent research indicates promise in anti-platelet therapy guidance.
Read More
A commentary on Medicare’s experience in attempting to improve the quality of heart failure care demonstrates just how hard it may be to get better outcomes and lower cost.
A Financial Times article details the British National Health Service’s struggles to implement a new health information system.
Earlier this year the California Department of Insurance was asked to allow a greater than 20% increase in workers’ compensation premiums. The Department’s response provides some interesting observations on the state of workers’ compensation medical cost control efforts.
USA Today published an article on the federal end-stage renal disease program. The problems are typical of most government health programs.
Aon has estimated that private insurers health costs will increase at over 10% next year.
An Op-ed suggests we spend too little on healthcare. That may depend on who is paying.
A recent report from NEHI states that medication therapy non-compliance leads to $290 billion in avoidable medical costs every year.
While Massachusetts is the state health care reform example most often referred to in the discussion over federal reform efforts, Tennessee’s earlier program to extend coverage may also offer lessons.
The physical distribution and payment flows for pharmaceuticals in the United States are very complex. A new report helps explain those processes.
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts